Travere Therapeutics to Report Second Quarter 2026 Financial Results
Go back to Travere Therapeutics to Report Second Quarter 2026 Financial Results| (NASDAQ: TVTX) | Delayed: 62.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.86 | 52 Week High | $ | |||
| Open | $62.86 | 52 Week Low | $ | |||
| Day High | $62.86 | P/E | N/A | |||
| Day Low | $62.86 | EPS | $ | |||
| Volume | 2,410 | |||||

